Early Access — free while we kick the tires
EdgarHawk

Brown Michael J

CEO & President

Director Officer
3 filings analyzed · 2 companies · Latest 2025-09-26

Never miss a filing from Brown Michael J

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Monopar Therapeutics MNPR 0 2 Net selling
EURONET WORLDWIDE, INC. EEFT 0 1 Net selling

Activity

September 2025
2025-09-26 Monopar Therapeutics MNPR Joint filing
high
Sell
550,229 shares
$34,999,957
Significance 8/10

CEO Chandler Robinson sold 550.2K shares of MNPR at $63.61 for $35.0M, reducing stake by 66.9%

Chandler Robinson, Chief Executive Officer, executed a substantial sale of 550,229 shares at $63.61, reducing his holdings from 822,255 shares to 272,026 shares—a reduction of 66.9% of his pre-transaction position. The $35.0M transaction represents a material liquidation of CEO equity holdings in a single transaction. This large-scale disposition by the company's top executive merits investor scrutiny regarding his commitment to the business and the confidence signaled by retaining only 272,026 shares going forward.

April 2025
2025-04-04 Monopar Therapeutics MNPR Joint filing
low
Sell
33,334 shares
$1,166,690
Significance 4/10

CEO Chandler Robinson sold 33,334 shares of MNPR at $35.00 for $1,166,690.00

Chandler Robinson, Chief Executive Officer, sold 33,334 shares on 2025-04-02 at $35.00, reducing his holdings from 855,589 shares to 822,255 shares. The sale generated $1,166,690.00 and represents a -3.9% reduction in his pre-transaction position. As a CEO with substantial remaining holdings of 822,255 shares, this modest-sized open-market sale warrants standard disclosure monitoring but does not signal abnormal portfolio activity or structural changes in executive positioning.

March 2025
medium
Sell
95,000 shares
$9,565,550
Significance 5/10

CEO Michael Brown sold 95,000 EEFT shares at $100.69 for $9.6M; retains 1.42M shares post-sale

Brown Michael J, CEO & President of Euronet Worldwide, sold 95,000 shares at $100.69 on 2025-03-13, reducing his holdings by 6.3% to 1,418,966 shares. The transaction generated $9,565,550.00 in proceeds at a price 4.2% below the current price of $105.07 and near the middle of the 52-week range of $92.68–$116.58. The company trades at a P/E of 12.89 with annual revenue growth of 8.2% and reported net income of $151,500,000.00 on $1,099,300,000.00 in latest quarterly revenue, reflecting steady operational performance. While the sale is material in absolute terms, the CEO maintains substantial remaining ownership of 1.42M shares, and the transaction occurred at a price not significantly distant from current levels, neither confirming undervaluation nor signaling distress.

Related insiders